Personal profile


Professor Roger Phillips was appointed Professor of Cancer Pharmacology in July 2014.

Following a BSc in Marine Biology and Biochemistry (Joint Honours) from University College of North Wales, Bangor, Roger specialised in Cancer Pharmacology gaining his PhD in 1988 from the University of Bradford (under Profs John Double and Mike Bibby). After an initial postdoctoral position in Bradford, he moved to the School of Pharmacy, University of Southern California, Los Angeles to work with Dr Neil Gibson in 1991. He returned to Bradford in 1993 and secured academic appointments as lecturer (1996 to 2001), Senior Lecturer (2001 to 2003) and Reader (2003 to 1014) in Cancer Pharmacology. In July 2014, Roger was appointed as Professor of Cancer Pharmacology at the University of Huddersfield. He was also appointed as Director of Research in the School of Applied Sciences in August 2015.

His research focuses on the preclinical and early clinical evaluation of novel anti-cancer drugs with a specific interest in the tumour microenvironment as a target for drug development. His research has had clinical impact through the development of EO9 as a therapeutic drug for the treatment of superficial bladder cancer. He has published extensively in internationally recognised journals, has successfully supervised over 20 PhD students and continues to present his work at national and international conferences. He is a committee member of the European Organisation for the Research and Treatment of Cancer (EORTC) Drug Development Committee and the Pharmacology and Molecular Mechanism Group. He is also an editorial board member for the British Journal of Pharmacology. 

Research Expertise and Interests

  • Preclinical development of novel anti-cancer drugs
  • Phenotype based screening
  • Development of experimental models that reflect the complexity of tumour biology
  • The hypoxic tumour microenvironment as a target for drug development
  • Drug delivery to hypoxic regions of solid tumours

Research Degree Supervision

Click Here to see all postgraduate research opportunities with Professor Roger Philips


  • Biochemistry
  • Molecular Medicine
  • Cancer Research
  • Drug Development
  • Biomarker Research
  • Pharmaceutics

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 1 Similar Profiles
apaziquone Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Cells Chemical Compounds
Tumors Chemical Compounds
Pharmaceutical Preparations Medicine & Life Sciences
Oxidoreductases Medicine & Life Sciences
NAD(P)H Dehydrogenase (Quinone) Medicine & Life Sciences
Indolequinones Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2018

  • 67 Article
  • 5 Review article
  • 2 Conference contribution
  • 1 Comment/debate
1 Citations

Cellular pharmacology studies of anticancer agents: recommendations from the EORTC-PAMM group

Perego, P., Hempel, G., Linder, S., Bradshaw, T. D., Larsen, A. K., Peters, G. J. & Phillips, R. M. 1 Mar 2018 In : Cancer Chemotherapy and Pharmacology. 81, 3, p. 427-441 15 p.

Research output: Contribution to journalReview article

Antineoplastic Agents
Coordination Complexes
Metal complexes

Health care for all: Effective, community supported, healthcare with innovative use of telemedicine technology

Shah, T. K., Tariq, T., Phillips, R., Davison, S., Hoare, A., Hasan, S. S. & Babar, Z-U-D. 1 Feb 2018 In : Journal of Pharmaceutical Policy and Practice. 11, 3, 3 p.

Research output: Contribution to journalArticle

Open Access
Community Health Services
Delivery of Health Care
Developing Countries

Polymer encapsulation of anticancer silver-N-heterocyclic carbene complexes

Mohamed, H. A., Khuphe, M., Boardman, S. J., Shepherd, S., Phillips, R., Harvey, P. D. & Willans, C. E. 15 Mar 2018 In : RSC Advances. 2018, 19, p. 10474-10477 4 p.

Research output: Contribution to journalArticle

Open Access
Block copolymers

Ruthenium-containing Linear Helicates and Mesocates with Tuneable p53 Selective Cytotoxicity in Colorectal Cancer Cells.

Rice, C., Faulkner, R., Allison, S., Cooke, D., Davidson, F. S., Elliott, P., Griffiths, H., Hussain, O., Owen-Lynch, P., Phillips, R., Shepherd, S. & Wheelhouse, R. T. 4 Jun 2018 (Accepted/In press) In : Angewandte Chemie - International Edition.

Research output: Contribution to journalArticle


Activities 2016 2016

  • 4 Examination
  • 2 Membership of committee
  • 1 Editorial work

External Examiner

Phillips, R. (Examiner)

Activity: Examination

External Examiner

Phillips, R. (Examiner)

Activity: Examination

British Journal of Pharmacology (Journal)

Phillips, R. (Member of editorial board)

Activity: Editorial work

External Examiner

Phillips, R. (Examiner)

Activity: Examination